156 related articles for article (PubMed ID: 23739704)
1. The use of ablative lasers in the treatment of facial melasma.
Morais OO; Lemos ÉF; Sousa MC; Gomes CM; Costa IM; Paula CD
An Bras Dermatol; 2013; 88(2):238-42. PubMed ID: 23739704
[TBL] [Abstract][Full Text] [Related]
2. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
3. Laser therapy in the treatment of melasma: a systematic review and meta-analysis.
Lai D; Zhou S; Cheng S; Liu H; Cui Y
Lasers Med Sci; 2022 Jun; 37(4):2099-2110. PubMed ID: 35122202
[TBL] [Abstract][Full Text] [Related]
4. Erbium:YAG laser resurfacing for refractory melasma.
Manaloto RM; Alster T
Dermatol Surg; 1999 Feb; 25(2):121-3. PubMed ID: 10037517
[TBL] [Abstract][Full Text] [Related]
5. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma.
Lyons AB; Moy RL; Herrmann JL
J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
7. Commentary on Clinical and Histopathological Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Morton LM
Dermatol Surg; 2016 Apr; 42(4):513-4. PubMed ID: 26949932
[No Abstract] [Full Text] [Related]
8. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA
Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146
[TBL] [Abstract][Full Text] [Related]
9. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
10. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
Attwa E; Khater M; Assaf M; Haleem MA
Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
[TBL] [Abstract][Full Text] [Related]
11. Lasers.
Passeron T
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S159-65. PubMed ID: 23522632
[TBL] [Abstract][Full Text] [Related]
12. Treating melasma with the 1064 nm Nd:YAG laser with a 650-microsecond pulse duration: A clinical evaluation.
Greywal T; Ortiz A
J Cosmet Dermatol; 2021 Dec; 20(12):3889-3892. PubMed ID: 34762366
[TBL] [Abstract][Full Text] [Related]
13. Parameters in fractional laser assisted delivery of topical anesthetics: Role of laser type and laser settings.
Meesters AA; Nieboer MJ; Kezic S; de Rie MA; Wolkerstorfer A
Lasers Surg Med; 2018 Oct; 50(8):813-818. PubMed ID: 29733110
[TBL] [Abstract][Full Text] [Related]
14. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
15. Clinical & ultrastructural evaluation of the effect of fractional CO2 laser on facial melasma.
El-Sinbawy ZG; Abdelnabi NM; Sarhan NE; Elgarhy LH
Ultrastruct Pathol; 2019; 43(4-5):135-144. PubMed ID: 31575311
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of fractional CO
Robati RM; Asadi E
Lasers Med Sci; 2017 Feb; 32(2):283-289. PubMed ID: 27885522
[TBL] [Abstract][Full Text] [Related]
17. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
[TBL] [Abstract][Full Text] [Related]
18. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
19. New application of the long-pulsed Nd-YAG laser as an ablative resurfacing tool for skin rejuvenation: a 7-year study.
Alshami MA
J Cosmet Dermatol; 2013 Sep; 12(3):170-8. PubMed ID: 23992158
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Ablative Fractional Laser in Melasma: A Meta-analysis and Systematic Review.
Zhao S; Wang M; Lai X; Yan Y
Lasers Med Sci; 2024 Feb; 39(1):71. PubMed ID: 38379033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
